GGrantIndex
Sort

51,570 grants matching autoimmune disease

Genetics and pathophysiology of systemic juvenile idiopathic arthritis and other complex autoinflammatory diseases

$704,629
Michael Ombrello · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR

Programming dendritic cells in concert with morphagen delivery for periodontal re

$704,509
David J Mooney · Harvard University · R01 · FY2011 · DE

Identify Rare Pathogenic Variants and their Functional Consequences in SLE

$704,424
Betty P. Tsao · Medical University Of South Carolina · R01 · FY2025 · AR

GENE REGULATORY EVENTS IN ESTABLISHING MATURE T CELL TOLERANCE

$704,412
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Synthetic toolkit for precision gene expression control and signal processing in mammalian cells

$704,349
Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2020 · EB

JAK Signaling as a Mechanism of Inflammation-related Reward and Motor Circuit Deficits in Depression

$704,271
Jennifer C Felger · Emory University · R01 · FY2025 · MH

Admin Core - Phase 2

$704,246
Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2024 · GM

Enhanced persistence of CAR Tregs in the CNS for Alzheimer’s disease therapy

$704,198
Charles L Sentman · Dartmouth College · R61 · FY2025 · AG

Vasculopathy and Systemic Sclerosis-Associated Interstitial Lung Disease

$704,161
Elana Bernstein · Columbia University Health Sciences · R01 · FY2023 · HL

Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice

$703,951
Martin D Burke · University Of Illinois At Urbana-Champaign · R01 · FY2019 · HL

Characterizing functional states of macrophages via their stimulus-responses

$703,874
Alexander Hoffmann · University Of California Los Angeles · R01 · FY2024 · AI

An experimentally-refined, dynamic gene regulatory network model of T-cell memory

$703,828
Artem Barski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · AI

DEVELOPMENT OF THE PRIMATE IMMUNOLOGY RESOURCE

$703,649
University Of California Davis · R24 · FY2003 · RR

Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17

$703,646
Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI

A Stress-Induced Vicious Cycle In The Development of T1D

$703,560
Peter Arvan · University Of Michigan At Ann Arbor · U01 · FY2023 · DK

A Stress-Induced Vicious Cycle In The Development of T1D

$703,560
Peter Arvan · University Of Michigan At Ann Arbor · U01 · FY2022 · DK

A Stress-Induced Vicious Cycle In The Development of T1D

$703,560
Peter Arvan · University Of Michigan At Ann Arbor · U01 · FY2021 · DK

Stem Cell Graft Engineering to Treat Sickle Cell Disease

$703,541
Suzanne T Ildstad · Regenerex, Llc · R42 · FY2009 · HL

Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD

$703,237
Linda A Sherman · Scripps Research Institute, The · U01 · FY2009 · AI

Early Detection of Breast Cancer Using Autoantibody Mar*

$703,194
Michael A Tainsky · Wayne State University · U01 · FY2008 · CA

Characterization of SLE-susceptibility loci on mouse chromosome 1

$703,044
Laurence Morel · University Of Texas Hlth Science Center · R01 · FY2024 · AI

UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes

$702,985
Stephen E Gitelman · University Of California, San Francisco · U01 · FY2009 · DK

Discovery and Assessment of Genetic Determinants of HCV and HIV Control

$702,924
Raymond T Chung · Massachusetts General Hospital · R01 · FY2012 · DA

Bacterial metabolites controlling Th17 and Treg cells

$702,873
Jun R. Huh · Harvard Medical School · R01 · FY2023 · DK

Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects

$702,706
Arthur A. Vandenbark · Virogenomics Biodevelopment, Inc. · R42 · FY2017 · AI